Prof. Dr. med. Wolfgang Herr
internal medicine, hematology, and oncology
internal medicine, hematology, and oncology
Overview
Country, City
Germany, Regensburg
Health facility
University Hospital Regensburg
Medical unit
Department of hematology, oncology, and stem cell transplantation
About the doctor
Skills & Expertise
stem cell
stem cell transplantation
leukemia
cd8
cancer
hematopoietic stem cell
cd4
myeloid leukemia
chemotherapy
tumor
carcinoma
gene
immunotherapy
hematology
liver
oncology
melanoma
lymphoma
bone
adenocarcinoma
hepatitis
lymphocyte
allogeneic transplantation
renal cell
internal medicine
langerhans cell
human immunodeficiency virus
lymphocytic leukemia
soft tissue
hepatocellular carcinoma
bone marrow
cd8depleted donorlymphocyte infusions
hemorrhagic telangiectasia
soft tissue tumors
pancreatic adenocarcinoma
renal carcinoma
multiple myeloma
nervous system
stromal cells
colorectal cancer
cell carcinoma
tcell therapy
lung cancer
bone soft tissue
pancreatic cancer
prostate carcinoma
ovarian carcinoma
renal cancer
prostate cancer
gastrointestinal tract
Resume
CV (Curriculum Vitae)
Education
- Studied human medicine
- Obtaining a license for medical practice
- 1992 Defense of the dissertation at the Johannes Gutenberg University Mainz
- Obtaining specialization in internal medicine
- Habilitation and a teaching license
- Received additional qualifications in the field of hematology and oncology
Experience
- Senior Physician for stem cell transplantation at the Johannes Gutenberg University Mainz
- Director of the Department of hematology, oncology, and stem cell transplantation at the University Hospital Regensburg
- Lecturer at the University Regensburg
Awards & Memberships
- Member of the Corps Hassia-Giessen at Mainz
- Member of the Corps Saxonia Konstanz and Corps Thuringia Jena
- Included in the FOCUS doctor's top lists in bone and soft tissue tumors, lymphomas, leukemia, and bone marrow diseases
Languages
English
German
Publications
Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥ 60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase.
26 October, 2023
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors.
19 October, 2023
MCT4 blockade increases the efficacy of immune checkpoint blockade.
October, 2023
Location
Franz-Josef-Strauß-Allee, 11, 93053 Regensburg, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Wolfgang Herr?
The primary specialization of the doctor is internal medicine, hematology, and oncology.
What is the experience of the specialist?
Prof. Dr. med. Wolfgang Herr has been practicing for more than 32 years.
Prof. Dr. med. Wolfgang Herr
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Wolfgang Herr